Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Circulation|January 30, 2013
Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure managementJames L Januzzi, Richard TroughtonThe New Zealand Medical Journal|June 21, 2022
Deactivation of implantable cardioverter defibrillators towards the end of life: a survey of perceptions and practice among New Zealand cliniciansTamara Brodie, Amanda Landers, Richard TroughtonEuropean Heart Journal|November 13, 2013
Natriuretic peptide-guided heart failure managementRichard Troughton, G Michael Felker, James L JanuzziJournal of Cardiac Failure|April 3, 2012
ST2 has diagnostic and prognostic utility for all-cause mortality and heart failure in patients presenting to the emergency department with chest painSally J Aldous, A Mark Richards, Richard Troughton, et al.The New Zealand Medical Journal|July 6, 2014
One-year follow-up of the 2011 Christchurch Earthquake stress cardiomyopathy casesChristina Chan, Richard Troughton, John Elliott, et al.Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Health gains by using natriuretic peptides in diagnosis, prognosis and treatmentMark Richards, Richard Troughton, John Lainchbury, et al.Plos One|November 18, 2022
Evaluation of the added value of Brain Natriuretic Peptide to a validated mortality risk-prediction model in older people using a standardised international clinical assessment toolJohn W Pickering, Richard Scrase, Richard Troughton, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 1, 2012
Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest painSally J Aldous, Mark Richards, Louise Cullen, et al.Journal of Cardiac Failure|June 11, 2005
Guiding and monitoring of heart failure therapy with NT-ProBNP: concepts and clinical studiesA Mark Richards, Richard Troughton, John Lainchbury, et al.American Heart Journal|October 17, 2012
A 2-hour thrombolysis in myocardial infarction score outperforms other risk stratification tools in patients presenting with possible acute coronary syndromes: comparison of chest pain risk stratification toolsSally J Aldous, Mark Richards, Louise Cullen, et al.Pageof 8